olmesartan has been researched along with Proteinuria in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horino, T; Ichii, O; Shimamura, Y; Terada, Y | 1 |
| Higashi, K; Kumagai, H; Kushiyama, T; Miura, S; Oda, T; Oshima, N; Sakurai, Y; Takechi, H; Uchida, T; Watanabe, A; Yamamoto, K | 1 |
| Fujigaki, Y; Fukasawa, H; Hishida, A; Huang, Y; Kitagawa, M; Misaki, T; Nakagawa, T; Nakamura, Y; Ohashi, N; Suzuki, F; Suzuki, H; Suzuki, S; Togawa, A; Yamamoto, T | 1 |
| Fukuda, Y; Iino, Y; Ishizaki, M; Katayama, Y; Kawachi, H; Masuda, Y; Mii, A; Shimizu, A | 1 |
| Ishida, A; Ito, O; Kanazawa, M; Kohzuki, M; Kurosawa, H; Lu, H; Ootaka, T; Sasaki, Y; Sato, T; Tufescu, A | 1 |
| Anraku, M; Hirata, S; Kadowaki, D; Maruyama, T; Otagiri, M; Seo, H; Shimoishi, K; Taguchi, K; Tasaki, Y | 1 |
| Kamide, K; Maekawa, Y; Ohishi, M; Onishi, M; Rakugi, H; Takeya, Y; Tatara, Y; Yamamoto, K | 1 |
| Kim, HJ; RodrÃguez-Iturbe, B; Sato, T; Vaziri, ND | 1 |
| Amaha, M; Kawagoe, Y; Maeda, S; Nakamura, T; Sato, E; Yamagishi, S | 1 |
| Chan, JC; Haneda, M; Imai, E; Ito, S; Kobayashi, F; Makino, H; Yamasaki, T | 1 |
| Fukuda, M; Ichikawa, T; Ito, A; Kato, Y; Kimura, G; Miura, T; Mizuno, M; Naito, T; Ono, M; Sasakawa, Y; Sato, R; Shirasawa, Y; Togawa, H; Tomonari, T; Yoshida, A | 1 |
| Azushima, K; Fujikawa, T; Kanaoka, T; Kobori, H; Maeda, A; Ohsawa, M; Tamura, K; Umemura, S; Wakui, H; Yanagi, M | 1 |
| Miura, S; Saku, K | 1 |
| Schmieder, RE | 1 |
| Abe, Y; Baba, R; Fan, YY; Fujita, M; Hosomi, N; Kimura, S; Kohno, M; Miyatake, A; Nagai, Y; Nishiyama, A; Sun, GP | 1 |
| Inoue, T; Kawagoe, Y; Koide, H; Nakamura, T; Node, K; Sugaya, T; Suzuki, T; Ueda, Y | 1 |
6 trial(s) available for olmesartan and Proteinuria
| Article | Year |
|---|---|
Strong suppression of the renin-angiotensin system has a renal-protective effect in hypertensive patients: high-dose ARB with ACE inhibitor (Hawaii) study.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Female; Hawaii; Humans; Hypertension; Imidazoles; Imidazolidines; Kidney; Kidney Diseases; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2010 |
Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria.
Topics: Adult; Amides; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Fatty Acid-Binding Proteins; Female; Fumarates; Humans; Imidazoles; Kidney Failure, Chronic; Kidney Tubules; Male; Proteinuria; Regression Analysis; Tetrazoles | 2012 |
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Stroke; Tetrazoles; Treatment Outcome | 2011 |
Predictors of proteinuria reduction by monotherapy with an angiotensin receptor blocker, olmesartan.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin Receptor Antagonists; Blood Pressure; Female; Glomerular Filtration Rate; Humans; Imidazoles; Male; Middle Aged; Prognosis; Proteinuria; Renin; Tetrazoles; Young Adult | 2012 |
The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Collagen Type IV; Comorbidity; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Imidazoles; Kidney; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Tetrazoles | 2013 |
Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Deoxyguanosine; Double-Blind Method; Drug Therapy, Combination; Fatty Acid-Binding Proteins; Female; Glomerulonephritis, IGA; Heart Rate; Humans; Imidazoles; Male; Proteinuria; Tetrazoles; Thiazepines | 2007 |
10 other study(ies) available for olmesartan and Proteinuria
| Article | Year |
|---|---|
Renal thrombotic microangiopathy caused by bevacizumab.
Topics: Adenocarcinoma of Lung; Aged; Angiogenesis Inhibitors; Angiotensin II Type 1 Receptor Blockers; Bevacizumab; Biopsy; Humans; Imidazoles; Kidney Diseases; Male; Proteinuria; Tetrazoles; Thrombotic Microangiopathies | 2018 |
Protective effects of Rho kinase inhibitor fasudil on rats with chronic kidney disease.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Angiotensin II Type 1 Receptor Blockers; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Enzyme Inhibitors; Hypercholesterolemia; Imidazoles; Kidney Glomerulus; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Membrane Proteins; Microscopy, Electron; Phenotype; Proteinuria; Rats; Receptors, Cell Surface; Renal Insufficiency, Chronic; rho-Associated Kinases; RNA, Messenger; Tetrazoles | 2013 |
Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Antilymphocyte Serum; Blood Pressure; Gene Expression; Glomerulonephritis, Membranoproliferative; Imidazoles; Kidney; Male; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles | 2008 |
Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Becaplermin; Biomarkers; Blood Pressure; Cell Proliferation; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Imidazoles; Kidney Glomerulus; Male; Platelet-Derived Growth Factor; Proteinuria; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tetrazoles; Thy-1 Antigens | 2009 |
Combination of chronic exercise and antihypertensive therapy enhances renoprotective effects in rats with renal ablation.
Topics: Ablation Techniques; Actins; Animals; Antihypertensive Agents; Azetidinecarboxylic Acid; Blood Urea Nitrogen; Combined Modality Therapy; Creatinine; Dihydropyridines; Exercise Therapy; Imidazoles; Kidney; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Inbred WKY; Tetrazoles | 2009 |
Evaluation for antioxidant and renoprotective activity of olmesartan using nephrectomy rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Creatinine; Imidazoles; Kidney; Male; Nephrectomy; Placebos; Proteinuria; Rats; Rats, Wistar; Serum Albumin; Tetrazoles | 2009 |
Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Kidney Diseases; Male; NF-E2 Transcription Factor; NF-kappa B; Oxidative Stress; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Thiobarbituric Acid Reactive Substances | 2011 |
How important is it to control nocturnal hypertension with angiotensin II type 1 receptor blockers?
Topics: Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Circadian Rhythm; Female; Humans; Hypertension; Imidazoles; Male; Proteinuria; Renal Insufficiency, Chronic; Tetrazoles | 2013 |
["High dosage monotherapy"].
Topics: Animals; Antihypertensive Agents; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypertension; Imidazoles; Patient Compliance; Proteinuria; Tetrazoles | 2005 |
Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatine; Hypertension; Imidazoles; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Male; Nephrectomy; Organ Size; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta | 2006 |